Bradley A. Erickson, MD, MS, discusses what he and his co-authors learned from developing a mobile app for assessing urologic chronic pelvic pain syndrome.
In this interview, Bradley A. Erickson, MD, MS, discusses the recent Urology Practice study, "A Mobile Phone Application (App) for Assessing Daily Variation in Pain Location and Pain Intensity in Patients With Urologic Chronic Pelvic Pain Syndrome (UCPPS): A MAPP Network Study," for which he served as a study author. Erickson is professor of urology at the University of Iowa, Iowa City.
More videos:
Testosterone therapy does not appear to worsen outcomes in men with COVID-19
HIFU for prostate cancer: How it works, criteria for treatment, and contraindications
Attorney Kenton H. Steele, Esq on the medico-legal dangers of friendly prescribing
Study examines patient knowledge of urinary tract infections
July 11th 2024"The objective of this study was to assess baseline knowledge about urinary tract infections, interest in health resources, and platform preferences for health information acquisition and dissemination," says Stephanie Gleicher, MD.
Destigmatizing Urology: Dr. Winter discusses STDs/STIs
March 22nd 2022“We need to just approach STIs as the medical conditions they are because until we do, and until we take those stigmas away, people will truly have resistance to discussing it, hesitance to discussing it, and resistance to diagnosis and intervention,” says Ashley Winter, MD.
Burden of care for recurrent UTI is higher for female urologists
June 15th 2024"What we believe is happening is women are seeking the help of female urologists, and therefore, because of the nature of the condition, the female urologists are absorbing the burden of the care of these patients, particularly the non-billable burden," says Debra L. Fromer, MD.
Predictive model quantifies risk of antibiotic resistance in uUTI
May 24th 2024The predictive models identified the number of previous UTI episodes, prior β-lactam nonsusceptibility, prior fluoroquinolone treatment, Census Bureau region (particularly in the South), and race as key predictors of having a non-susceptible isolate to 3 or more antibiotic classes.